智通财经APP获悉，首都机场(00694)跌超3%，截至发稿，跌3.09%，报2.51港元，成交额4374万港元。 消息面上，近日，首都机场发布2025年业绩盈警预告，大摩研报指出，首都机场2025年净亏损远超市场 预期，预计亏损金额6亿至7.6亿元人民币之间，显著高于市场预测的2.16亿元人民币。即使剔除税务影 响，其税前亏损仍达到4.8亿至5.6亿元人民币，表现逊于预期。该行认为，当前公司股价仍有下行空 间。 该行续指，公司2025年第四季度的税前亏损范围为1.7亿至2.5亿元人民币，同比亏损幅度有所扩大。这 一结果表明，公司在该季度的经营压力持续加剧，未能实现有效的成本控制或收入增长以缓解亏损局 面。此外，全年亏损规模的扩大也反映出行业环境及公司自身运营面临的严峻挑战。 ...

消息面上，近日，首都机场发布2025年业绩盈警预告，大摩研报指出，首都机场2025年净亏损远超市场 预期，预计亏损金额6亿至7.6亿元人民币之间，显著高于市场预测的2.16亿元人民币。即使剔除税务影 响，其税前亏损仍达到4.8亿至5.6亿元人民币，表现逊于预期。该行认为，当前公司股价仍有下行空 间。 该行续指，公司2025年第四季度的税前亏损范围为1.7亿至2.5亿元人民币，同比亏损幅度有所扩大。这 一结果表明，公司在该季度的经营压力持续加剧，未能实现有效的成本控制或收入增长以缓解亏损局 面。此外，全年亏损规模的扩大也反映出行业环境及公司自身运营面临的严峻挑战。 首都机场(00694)跌超3%，截至发稿，跌3.09%，报2.51港元，成交额4374万港元。 ...

经济观察网 银之杰（300085）发布2025年度业绩预告，预计全年归母净利润亏损1.1亿元至1.4亿元，若 最终确认将连续第五年亏损。亏损主因是金融信息技术业务收入下降约35.94%、移动信息服务业务收 入下降约30.94%，以及计提无形资产减值、股份支付费用（影响约-2740万元）和战略投资东亚前海证 券亏损（影响约-1560万元）所致。唯一亮点是电子商务业务收入增长约15.49%，但不足以抵消整体下 滑。 机构观点 机构对银之杰关注度较低，最新舆情偏中性，无近期调研记录。盈利预测方面，有机构预计2025年净利 润为7100万元，但与公司业绩预告的亏损状态存在显著分歧。基金持股比例仅0.04%，市场情绪谨慎。 以上内容基于公开资料整理，不构成投资建议。 股票近期走势 2026年2月5日，银之杰股价逆势上涨2.15%，单日成交金额达13.98亿元，换手率5.39%，显示短期资金 关注度较高。但此后股价回调，截至2月11日收盘价38.66元，较2月5日下跌3.18%，近20日跌幅达 17.95%，弱于大盘和行业指数。当前技术面显示股价处于布林带下轨36.71元附近震荡，压力位在43.85 元。 公司结构与治理 ...

Core Viewpoint - The company Guangyun Da (光韵达) is expected to report a significant increase in losses for the year 2025, which has impacted market sentiment and led to fluctuations in its stock price [1][2] Group 1: Performance Forecast - Guangyun Da's performance forecast for 2025 indicates a projected net loss attributable to shareholders of between 240 million yuan and 300 million yuan, a substantial increase from the 27.37 million yuan loss in 2024 [2] - The primary reasons for the increased losses include intense competition in the smart equipment sector leading to inventory impairment, a decline in gross profit from the aviation parts business, goodwill impairment, and the accrual of stock incentive expenses [2] Group 2: Stock Performance - Over the past week, Guangyun Da's stock price has shown volatility, closing at 13.09 yuan on February 11, 2026, which is a 2.11% increase from the previous week's closing price of 12.82 yuan [1] - On February 9, 2026, there was a net inflow of 13.69 million yuan from major funds, contributing to a 4.26% increase in stock price, while on February 10, 2026, a net inflow of 6.04 million yuan was recorded, but the stock price fell by 0.83% [1] - The stock has recently broken through the 20-day moving average but faces resistance around the 13.77 yuan level [1]

Core Viewpoint - The recent performance of Aidewei Construction Group (06189.HK) indicates an expanding loss for the mid-year results of 2025, alongside ongoing challenges in the industry environment [1]. Financial Performance - The mid-year report for the fiscal year 2025, disclosed on September 3, 2025, shows a net loss of 16.871 million RMB, representing a year-on-year increase in loss of 98.16% [2]. - Despite a significant year-on-year revenue growth of 326.40%, the revenue base was extremely low at only 840,000 RMB, highlighting that the main business areas (construction decoration, electromechanical installation, etc.) are still under considerable pressure [2]. Industry Policy and Environment - The construction decoration industry in 2025 is adversely affected by sluggish real estate investment, leading to continued exposure of credit risks among smaller firms [3]. - As a smaller Hong Kong-listed construction company, Aidewei's business recovery is highly dependent on the rebound of the real estate chain and its ability to secure new projects, necessitating attention to potential improvements in cash flow through business adjustments or policy support [3]. Future Development - The company has not yet announced the specific date for the full-year results of 2025, but it is expected to be disclosed between March and April 2026 [4]. - Key areas to monitor in the upcoming financial report include whether the annual loss narrows, the scale of new orders, and the liquidity situation [4].

Core Viewpoint - Songyang Resources (603863) is experiencing continuous losses, with significant share pledges by the controlling shareholder and divestment of non-core subsidiaries to focus on its main business, alongside management changes [1]. Financial Performance - According to the earnings forecast released on January 20, 2026, Songyang Resources expects a net profit loss attributable to shareholders of between 160 million to 210 million yuan for the full year of 2025, marking the fourth consecutive year of losses since 2022. Although the loss scale is slightly narrowed compared to 2024, the main business still faces challenges from weak downstream demand, inverted product prices, and asset impairment pressures. The formal annual report and subsequent operational improvement effects are worth monitoring [2]. Shareholder Pledge - A notice on December 30, 2025, revealed that the controlling shareholder Wang Zhuangpeng and his concerted parties have extended the pledge of shares, with a cumulative pledged shareholding ratio reaching 96.47%. The announcement emphasized that risks are controllable, with repayment funds sourced from operating income, but the high pledge ratio may raise market concerns regarding share stability [3]. Subsidiary Development - On December 30, 2025, the company announced the transfer of 51% equity in its controlling subsidiary Songyang Le Cai for 1 yuan, exiting the non-core lottery business to optimize its asset structure and focus on the recycling resources main business. This adjustment may be viewed by the market as a signal to enhance operational efficiency [4]. Management Changes - On December 18, 2025, Songyang Resources announced the resignation of former general manager Wang Weilong due to personal reasons, with the board appointing Cai Jiantao as the new general manager. This personnel change may impact the strategic execution of the company [5]. Strategic Advancement - Following the termination of control transfer in 2025, the company has shifted to introduce external cooperation, such as signing a production management service contract with Hubei Changjiang Huifeng Paper Industry, aimed at enhancing the capacity and quality of high-strength corrugated paper. This initiative is part of the company's strategy to narrow its focus and return to core business, but its effectiveness will require time to validate [6].

格隆汇2月10日丨中粮家佳康(01610.HK)公告，根据其对集团截至2025年12月31日止年度(「2025年 度」)的未经审核综合管理账目及董事会目前可得资料的初步评估，预期集团2025年度生物资产公允价 值调整前(「调整前」)的公司拥有人应占亏损约为人民币2.3亿元至人民币3.5亿元(未经审核)，去年同期 调整前应占溢利约为人民币2.59亿元。 董事会认为，集团调整前业绩由盈转亏，主要由于以下原因：期内生猪销售价格同比大幅下降，持续于 低位运行，养殖业务利润空间受到挤压，虽期内养殖成本有所改善，生鲜品牌业务有较大突破，科技驱 动成效有所显现，但整体盈利水平同比下降。 ...

Group 1 - The core issue is that Nanjing Pharmaceutical is under investigation by the China Securities Regulatory Commission for violations in annual report disclosures, highlighting significant flaws in the company's financial compliance [1][4] - The company has faced repeated accounting errors, including improper handling of sales returns and insufficient conditions for revenue recognition, leading to restatements of financial data [1][4] - The investigation represents a critical examination of the company's integrity and governance, emphasizing the importance for affected investors to protect their rights within the legal framework [1][4] Group 2 - Nanjing Pharmaceutical has announced a projected annual revenue of 120 million to 150 million yuan for 2025, a decline of approximately 43% to 54% compared to the previous year's revenue of 263 million yuan [2][4] - The company anticipates a net loss of 120 million to 160 million yuan, although this represents a reduction from the previous year's loss of 357 million yuan, indicating ongoing challenges in achieving profitability [2][4] - Factors contributing to the performance decline include intensified competition in the pharmaceutical industry and reduced demand for core products due to a decrease in flu cases, alongside a cautious approach to asset and credit impairment losses [2][5]

Group 1 - The core viewpoint of the article highlights the multiple challenges faced by Rongbai Technology, a leading company in the lithium battery ternary material sector, including performance losses, domestic regulatory investigations, and overseas patent infringement disputes [2] Group 2 - Rongbai Technology's subsidiary, Jaese Ningwon, is facing a temporary injunction application from LG Chem, claiming patent infringement related to key technologies in cathode materials [4][5] - If the injunction is granted, Jaese Ningwon's production line of 70,000 tons, sufficient for supplying cathode materials for approximately 700,000 electric vehicles, will be halted, significantly impacting Rongbai Technology's overseas operations [5][6] - Rongbai Technology asserts that its products do not infringe on LG Chem's patents and is actively defending its rights through legal channels [6] Group 3 - In the domestic market, Rongbai Technology has been fined 9.5 million yuan due to misleading statements related to a major contract with CATL, which raised regulatory concerns [8][12] - The contract involves supplying 3.05 million tons of lithium iron phosphate cathode materials, estimated to exceed 120 billion yuan in sales, but the company has limited capacity in this area, leading to a significant production gap [9][11][12] - The company has acknowledged that the previously announced sales figures were based on market estimates and not guaranteed, resulting in a disclosure flaw [12] Group 4 - Rongbai Technology is projected to report its first annual loss since its listing, with an expected net loss of 150 to 190 million yuan for 2025, attributed to a shift in industry dynamics favoring lithium iron phosphate batteries over ternary batteries [13][14] - Despite the challenges, there are signs of recovery, with a projected net profit of approximately 30 million yuan in Q4 2025, driven by high sales volumes of cathode materials [14] - The company is shifting its focus towards lithium iron phosphate and sodium battery materials to adapt to industry trends and mitigate performance pressures [15]

Core Viewpoint - Keda Guochuang (300520.SZ) announced a share transfer agreement where its controlling shareholder, Hefei Guochuang Intelligent Technology Co., Ltd., will transfer 14,610,000 shares (5.00% of total shares) to Beijing Zhide Longteng Fund Management Co., Ltd. at a price of 37.43 CNY per share, totaling approximately 546.85 million CNY [1][2]. Group 1: Share Transfer Details - The share transfer does not trigger a mandatory bid, does not constitute a related party transaction, and will not change the controlling shareholder or actual controller of the company [2]. - The transferee, Zhide Longteng, commits not to reduce its holdings of the transferred shares for 12 months after the transfer is completed [2]. Group 2: Financial Performance Forecast - Keda Guochuang expects a net loss attributable to shareholders of 140 million to 190 million CNY for 2025, with revenue projected between 1.3 billion and 1.6 billion CNY [3][4]. - The company reported a significant decline in revenue, with a forecasted decrease of 24.45% compared to the previous year [5].